Li-Yuan Yu-Lee Selected Research

osteoblast cadherin

12/2015	Cadherin-11 endocytosis through binding to clathrin promotes cadherin-11-mediated migration in prostate cancer cells.
3/2015	Angiomotin is a novel component of cadherin-11/β-catenin/p120 complex and is critical for cadherin-11-mediated cell migration.
11/2013	Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis.
6/2010	Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts.
5/2010	Androgen depletion up-regulates cadherin-11 expression in prostate cancer.
8/2008	Cadherin-11 promotes the metastasis of prostate cancer cells to bone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li-Yuan Yu-Lee Research Topics

Disease

28	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2003
21	Neoplasms (Cancer) 01/2022 - 01/2003
20	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2004
4	Carcinogenesis 01/2018 - 04/2004
1	Heterotopic Ossification (Ectopic Ossification) 01/2022
1	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 01/2022
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 02/2017
1	Inflammation (Inflammations) 01/2017
1	Acute Lung Injury 01/2017
1	Edema (Dropsy) 01/2017
1	Atherosclerosis 01/2017
1	Sepsis (Septicemia) 01/2017
1	Pneumonia (Pneumonitis) 01/2017
1	Triple Negative Breast Neoplasms 11/2014
1	Lymphatic Metastasis 04/2013
1	Adenocarcinoma 02/2012
1	Lissencephaly 02/2010
1	Breast Neoplasms (Breast Cancer) 05/2004

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2004
6	osteoblast cadherinIBA 12/2015 - 08/2008
4	Protein Isoforms (Isoforms)IBA 01/2022 - 06/2004
4	AndrogensIBA 01/2021 - 07/2007
4	Conditioned Culture MediaIBA 01/2018 - 03/2015
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2017 - 11/2010
3	Cell Adhesion MoleculesIBA 12/2015 - 05/2010
2	cabozantinibIBA 09/2017 - 11/2015
2	IntegrinsIBA 11/2015 - 04/2013
2	Cadherins (E-Cadherin)IBA 03/2015 - 11/2013
1	PalovaroteneIBA 01/2022
1	Bone Morphogenetic Protein 4IBA 01/2022
1	TenascinIBA 01/2022
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022
1	CateninsIBA 04/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Radium-223IBA 12/2018
1	CalciumIBA 01/2018
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2018
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018
1	AngiomotinsIBA 02/2017
1	LipopolysaccharidesIBA 01/2017
1	EndotoxinsIBA 01/2017
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2017
1	CytokinesIBA 01/2017
1	Polo-Like Kinase 1IBA 09/2016
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 09/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2016
1	ClathrinIBA 12/2015
1	PF-562271IBA 11/2015
1	Galectins (Galectin)IBA 03/2015
1	Protein Kinases (Protein Kinase)IBA 02/2015
1	Lysine (L-Lysine)FDA Link 10/2012
1	Biomarkers (Surrogate Marker)IBA 02/2012
1	KataninIBA 02/2012
1	LDN 193189IBA 08/2011
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010
1	Cytoplasmic DyneinsIBA 02/2010
1	Small Interfering RNA (siRNA)IBA 08/2008
1	Docetaxel (Taxotere)FDA Link 06/2008
1	OsteonectinIBA 07/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2007
1	ErbB Receptors (EGF Receptor)IBA 07/2007
1	Hormones (Hormone)IBA 07/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2006
1	Biological ProductsIBA 06/2004
1	Growth Factor ReceptorsIBA 06/2004
1	Transcription Factors (Transcription Factor)IBA 05/2004
1	CEACAM1 ProteinIBA 05/2004
1	Dyneins (Dynein)IBA 04/2004
1	Pharmaceutical PreparationsIBA 04/2004
1	ProlactinIBA 01/2003

Therapy/Procedure

13	Therapeutics 01/2022 - 01/2003
3	Castration 01/2021 - 07/2007
2	Prostatectomy (Retropubic Prostatectomy) 12/2019 - 01/2018
1	Withholding Treatment 11/2015